Discover
MIRM
Mirum Pharmaceuticals, Inc.
99.67
1 x 99.55
1 x 99.79
bid
ask
+
0.97
0.98%
01:34 PM
timesize
| Ytd | 26.18% | |
| 1y | 51.31% |
98.25
day range
100.87
63.23
52 week range
130.00
| Open | 98.25 | Prev Close | 98.70 | Low | 98.25 | High | 100.87 | Mkt Cap | 6.08B |
| Vol | 193.77K | Avg Vol | 965.67K | EPS | -14.55 | P/E | -6.85 | Forward P/E | -290.33 |
| Beta | 0.52 | Short Ratio | 6.69 | Inst. Own | 109.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 109.69 | 200-d Avg | 93.35 | 1yr Est | 138.21 |
| Income Statement | |||
| Total Revenue | 176.24M | ||
| Revenues (USD) | 176.24M | ||
| Cost of Revenue | 30.35M | ||
| Gross Profit | 145.90M | ||
| Operating Expenses | 188.43M | ||
| Research and Development Expense | 90.53M | ||
| Selling, General and Administrative Expense | 81.47M | ||
| Operating Income | -42.54M | ||
| Interest Expense | 2.62M | ||
| Income Tax Expense | 1.69M | ||
| Net Income | -67.23M | ||
| Net Income Common Stock | -67.23M | ||
| Net Income Common Stock (USD) | -67.23M | ||
| Consolidated Income | -67.23M | ||
| Earnings per Basic Share | -1.06 | ||
| Earnings per Basic Share (USD) | -1.06 | ||
| Earnings per Diluted Share | -1.06 | ||
| Earning Before Interest & Taxes (EBIT) | -62.92M | ||
| Earning Before Interest & Taxes (USD) | -62.92M | ||
| Weighted Average Shares | 63.37M | ||
| Weighted Average Shares Diluted | 63.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 332.46M | ||
| Cash and Equivalents (USD) | 332.46M | ||
| Investments | 230.59M | ||
| Investments Current | 107.56M | ||
| Investments Non-Current | 123.03M | ||
| Trade and Non-Trade Receivables | 145.36M | ||
| Current Assets | 636.31M | ||
| Property, Plant & Equipment Net | 14.28M | ||
| Total Assets | 1.04B | ||
| Total Debt | 760.54M | ||
| Current Liabilities | 222.79M | ||
| Debt Non-Current | 760.54M | ||
| Total Liabilities | 1.06B | ||
| Accumulated Retained Earnings (Deficit) | -1.52B | ||
| Accumulated Other Comprehensive Income | -674.00K | ||
| Shareholders Equity | -10.42M | ||
| Shareholders Equity (USD) | -10.42M | ||
| Assets Non-Current | 408.67M | ||
| Total Debt (USD) | 760.54M | ||
| Goodwill and Intangible Assets | 247.39M | ||
| Inventory | 25.77M | ||
| Liabilities Non-Current | 832.62M | ||
| Trade and Non-Trade Payables | 23.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.53M | ||
| Net Cash Flow from Financing | 211.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.82M | ||
| Capital Expenditure | -23.00K | ||
| Issuance (Purchase) of Equity Shares | 13.37M | ||
| Issuance (Repayment) of Debt Securities | 198.07M | ||
| Net Cash Flow from Investing | -159.99M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -134.97M | ||
| Net Cash Flow from Operations | -44.25M | ||
| Effect of Exchange Rate Changes on Cash | -1.37M | ||
| Share Based Compensation | 30.57M | ||